Beijing Tong Ren Tang Chinese Medicine Company Limited (referred to as "BTRT") has once again distinguished itself on the global stage by securing the prestigious Gold Award in the Sustainable Development Category at the Quam IR Awards – The Most Remarkable Investor Relations Awards (QIRA) 2024. This marks the third consecutive year that the company has been recognized with this accolade, underscoring its unwavering commitment to integrating sustainable development principles into its corporate strategy and operations.

The QIRA 2024 awards, organized by Quamnet Investor Relations, a member of Quam Plus International Financial Limited (HKEX: 00952), celebrate excellence in investor relations and corporate responsibility among Hong Kong-listed companies. With a robust platform that connects a vast investor community and financial media network, Quamnet enjoys a strong reputation for credibility and influence in the market. This year’s awards ceremony highlighted BTRT’s exemplary efforts in sustainable development, positioning it among industry leaders in the awardees.

BTRT’s repeated success at QIRA reflects its strategic focus on embedding sustainability into its core business practices. By aligning its operations with global sustainability goals, the company has not only enhanced its corporate reputation but also set a benchmark for high-quality, sustainable growth in the Chinese medicine industry. This recognition affirms the company’s contributions to advancing sustainable practices and reinforces its leadership in promoting the long-term development of traditional Chinese medicine.

Looking ahead, BTRT remains committed to deepening its sustainability initiatives, upholding rigorous standards of corporate responsibility, and continuing to drive innovation and excellence in industry.